A detailed history of Voya Investment Management LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 27,116 shares of ETNB stock, worth $239,163. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,116
Previous 27,336 0.8%
Holding current value
$239,163
Previous $218,000 8.26%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.36 - $9.66 $1,619 - $2,125
-220 Reduced 0.8%
27,116 $200,000
Q2 2024

Aug 14, 2024

BUY
$7.31 - $10.9 $17,997 - $26,835
2,462 Added 9.9%
27,336 $218,000
Q1 2024

May 15, 2024

SELL
$8.13 - $13.77 $3,812 - $6,458
-469 Reduced 1.85%
24,874 $289,000
Q4 2023

Feb 14, 2024

BUY
$6.66 - $16.03 $3,183 - $7,662
478 Added 1.92%
25,343 $283,000
Q3 2023

Nov 14, 2023

BUY
$15.06 - $19.41 $4,939 - $6,366
328 Added 1.34%
24,865 $383,000
Q2 2023

Aug 14, 2023

BUY
$14.15 - $22.03 $347,198 - $540,550
24,537 New
24,537 $464,000

Others Institutions Holding ETNB

About 89bio, Inc.


  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $410M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.